MEDPLUS HEALTH SERVICES
|
|
BOM : 543427     NSE : MEDPLUS     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : NA |
Feb 06,2023 |
Price(EOD): ₹ 655.45
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 7,819.52 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
MEDPLUS HEALTH SERVICES | 3.1% | 7.5% | -42.4% |
SUN PHARMACEUTICAL INDUSTRIES | -1.1% | 0.8% | 15.6% |
DIVIS LABORATORIES | -16.3% | -19.7% | -31.6% |
CIPLA | 1.3% | -5.4% | 7.5% |
DR REDDYS LABORATORIES | 0.6% | 1.3% | -1.3% |
TORRENT PHARMACEUTICALS | 1.2% | -1.3% | 12% |
ABBOTT INDIA | 0.2% | -5.5% | 28.7% |
ZYDUS LIFESCIENCES | 9.2% | 8.7% | 4.7% |
ALKEM LABORATORIES | 2% | 0.9% | -14% |
FUNDAMENTAL ANALYSIS OF MEDPLUS HEALTH SERVICES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF MEDPLUS HEALTH SERVICES
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
223.63
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 34.97 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] 5.56
P/B Calculated based on Book Value of Rs 1,406.38 Cr
[Latest Year - Mar2022 - Consolidated Results ] 1.83
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 4,270.50 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
2662% 20512% -48% |
SHARE PRICE MOMENTUM OF MEDPLUS HEALTH SERVICES
MEDPLUS HEALTH SERVICES vs SENSEX
DEBT OF MEDPLUS HEALTH SERVICES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0 0 0 - |
0.1 0.2 0.36 0.22 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF MEDPLUS HEALTH SERVICES
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF MEDPLUS HEALTH SERVICES
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
6.22% 20.21% 83.76% 106.56% |
27.52% 16.75% -25.46% -20.9% |
QtrlyTrend |
4 | |
Latest Qtr: Dec2022 | ||
Quarterly Result Analysis → |
MEDPLUS HEALTH SERVICES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 250 SMALLCAP | 2% | -2.7% | -5.1% |
S&P BSE 400 MIDSMALLCAP | 1.8% | -2.2% | -1.7% |
S&P BSE CONSUMER DISC. | 1.5% | -1.2% | -2.7% |
S&P BSE SMALL CAP | 1.5% | -3.4% | -5.1% |
S&P BSE MIDSMALLCAP | 1.5% | -3% | -3.2% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY FREE SMALL 100 | 2.5% | -2.7% | -15.3% |
NIFTY SMALLCAP 50 | 2.3% | -1.8% | -17.6% |
NIFTY SMALLCAP250 | 1.8% | -3.1% | -7.1% |
NIFTY MID SMALL400 | 1.7% | -2.6% | -1.8% |
NIFTY500 MULTICAP 50:25:25 | 1% | -2.9% | -2.1% |
You may also like the below Video Courses
FAQ about MEDPLUS HEALTH SERVICES
Is MEDPLUS HEALTH SERVICES good for long term investment?
As on Feb 06,2023, the Fundamentals of MEDPLUS HEALTH SERVICES look Strong and hence it may be good for long term investment! See Financial Performance of MEDPLUS HEALTH SERVICES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is MEDPLUS HEALTH SERVICES UnderValued or OverValued?
As on Feb 06,2023, MEDPLUS HEALTH SERVICES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of MEDPLUS HEALTH SERVICES ?
As on Feb 06,2023, the Intrinsic Value of MEDPLUS HEALTH SERVICES is Rs. 23.73 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 23.73
Fair Value [Median EV / Sales Model] : Rs. 3.18
Fair Value [Median Price / Sales Model] : Rs. 1,266.39
Estimated Median Fair Value of MEDPLUS HEALTH SERVICES : Rs. 23.73
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is MEDPLUS HEALTH SERVICES trading at a Premium or Discount?
As on Feb 06,2023, MEDPLUS HEALTH SERVICES is trading at a Premium of 2662% based on the estimates of Median Intrinsic Value!